Yüklüyor......

Cardioprotective interventions for cancer patients receiving anthracyclines

BACKGROUND: Anthracyclines are among the most effective chemotherapeutic agents in the treatment of numerous malignancies. Unfortunately, their use is limited by a dose‐dependent cardiotoxicity. In an effort to prevent this cardiotoxicity, different cardioprotective agents have been studied. OBJECTI...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: van Dalen, Elvira C, Caron, Huib N, Dickinson, Heather O, Kremer, Leontien CM
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2011
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6457676/
https://ncbi.nlm.nih.gov/pubmed/21678342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003917.pub4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!